FormulaFolio Investments’s iBio IBIO Stock Holding History

FormulaFolio Investments’s Portfolio IBIO Stock Details IBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-46	Closed	-$51K	–	329
2020 Q2	$51K	Buy	+46	New	+$30.1K	﹤0.01%	287

Other funds holding IBIO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

FormulaFolio Investments's IBIO Position: Q3 2020 in Review

FormulaFolio Investments sold out of iBio (IBIO) in Q3 2020, closing a stake of 46 shares — an estimated $51K sold.

FormulaFolio Investments first reported a position in IBIO in Q2 2020 and held it in 1 quarter. The position peaked at $51K in Q2 2020. 77 funds tracked by Wall St. Rank hold IBIO as of Q3 2020.

FormulaFolio Investments reported no remaining iBio position as of Q3 2020 after selling out during the quarter.
FormulaFolio Investments sold 46 iBio shares in Q3 2020, an estimated $51K.
FormulaFolio Investments first reported a position in iBio in Q2 2020 and held it in 1 quarter.
FormulaFolio Investments's iBio position peaked at $51K in Q2 2020.
77 funds tracked by Wall St. Rank held iBio as of Q3 2020.

Based on FormulaFolio Investments's 13F filing for Q3 2020, filed 15 Oct 2020.